One of the possible causes for the supply drought is the shaky test-to-treat initiative, which faces fewer COVID-19 tests and a public wary of taking a new medication.
The GoodRx study also revealed an even distribution of Paxlovid to racial minorities in urban areas, including Black, Hispanic, Asian and Native American populations.
To determine how Paxlovid was distributed, GoodRx used HHS data detailing the number of publicly available Paxlovid courses distributed by county.
After gaining FDA approval and being available at the end of 2021, Paxlovid recently surpassed other antiviral treatments. In clinical trials, the Pfizer drug had an 89 percent efficacy rate in reducing the risk of hospitalization or death in adults.
Becker’s 3rd Annual Fall Chief Pharmacy Officer Summit is the top tier event that the people leading the future of pharmacy convene. This 3-day event is built specifically for Chief Pharmacy Officers and senior pharmacy leaders. The sessions examine the workforce, financial and clinical priorities shaping pharmacy today. Becker’s is where candid discussions flourish and new ideas thrive. Becker's 3rd Annual Fall Chief Pharmacy Officer Summit
